By Elaine Rigoli
Tampa, Fla., April 24 - Pelican Life Sciences has secured $100 million in private equity funding raised through Grotech Capital Group and Ferrer Freeman & Co., LLC.
The funding will be used to acquire companies as well as to make investments in the acquired entities to support product development, streamline manufacturing operations and expand sales and marketing capabilities, according to a news release.
Based in Charlotte, N.C., Pelican's product mix includes microbiology, molecular biology and non-commodity, specialty consumables.
| Issuer: | Pelican Life Sciences
|
| Issue: | Equity financing
|
| Amount: | $100 million
|
| Investors: | Grotech Capital Group and Ferrer Freeman & Co., LLC
|
| Announcement date: | April 24
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
